WINTWindtree TherapeuticsWINT info
$3.23info-2.71%24h
Global rank30887
Market cap$16.63M
Change 7d3.53%
YTD Performance368.12%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Windtree Therapeutics (WINT) Stock Overview

    Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company's lead development programs include istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as in Phase 2a clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase 2b clinical trial to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant, which is in Phase 2a clinical trial for the treatment of lung injury resulting from COVID-19; Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activator, which is in preclinical trial for the treatment of chronic and acute heart failure. Windtree Therapeutics, Inc. has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. The company was founded in 1992 and is headquartered in Warrington, Pennsylvania.

    WINT Stock Information

    Symbol
    WINT
    Address
    2600 Kelly RoadWarrington, PA 18976-3622United States
    Founded
    -
    Trading hours
    -
    Website
    https://windtreetx.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    215 488 9300

    Windtree Therapeutics (WINT) Price Chart

    -
    Value:-

    Windtree Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.23
    N/A
    Market Cap
    $16.63M
    N/A
    Shares Outstanding
    5.15M
    N/A
    Employees
    20.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org